Breast neuroendocrine tumors multidisciplinary treatment. Single experience in our Centre
Article Sidebar
Main Article Content
Abstract
Introduction: Breast Neuroendocrine Tumours (B-NETs) are rare entities; the incidence in Italy is about 1%. The great variability of manifestations and localizations made it very interested in studying. Only few cases are available in literature; actually this pathology is more difficult to treat because specific guidelines don’t exist for the treatment of primary metastatic NETs.
Case presentation: The case concerns a 48-year-old woman with a diagnosis of Breast Neuroendocrine Tumours (B-NET). She was treated with multidisciplinary approach; the patient started neoadjuvant chemotherapy and then she underwent right radical mastectomy. No further chemotherapy treatment was performed. In the last ten years, no signs of local recurrence or metastases were observed.
Conclusion: The presented case is very characteristic for its multidisciplinary approach.
Downloads
Article Details
Copyright (c) 2020 Curto LS, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Locurto P, Antona AD, Grillo A, Ciulla A, Martorana S, et al. (2016) Primary neuroendocrine carcinoma of the breast A single Center experience and review of the literature. Ann Ital Chir 87. Link: https://bit.ly/2VH72x8
Aoim Guidelines: Neuroendocrine neoplasia 2019.
Bussolati G, Badve S (2012) Carcinomas with neuroendocrine features. En: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editores. WHO classification of tumours of the breast. Lyon, France: IARC Press 62-63.
Ellis IO, Schnitt SJ, Sastre-Garau X, et al. (2003) Invasive breast carcinoma. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press 32-34.
Angarita FA, Rodriquez JL, Meek E, Sanchez JO, Tawil M, et al. (2013) Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature. World J Surg Oncol 11: 128. Link: https://bit.ly/3irotM8
Cloyd JM, Yang RL, Allison KH, Norton JA, Hernandez-Boussard T, et al. (2014) Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast. Breast Cancer Res Treat 148: 637-664. Link: https://bit.ly/3ip9CSk
Park YM, Wu Y, Wei W, Yang WT (2014) Primary neuroendocrine carcinoma of the breast: Clinical, imaging, and histologic features. AJR Am J Roentgenol 203: W221-W230. Link: https://bit.ly/3gr5xLt
Yoon YS, Kim SY, Lee JH, Kim SY, Han SW (2014) Primary neuroendocrine carcinoma of the breast: radiologic and pathologic correlation. Clin Imaging 38: 734‐738. Link: https://bit.ly/31H9Dvc
Aiom Guidelines: Breast cancer- 2009.
Morrow M, Goldstein L (2006) Surgery of the Primary Tumor in Metastatic Breast Cancer: closing the barn door after the horse has bolted? J Clin Oncol 24: 2694-2696. Link: https://bit.ly/38mLGdT